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ABSTRACT
Every year there are 10 thousand new cases of patients victimized by spinal cord trauma
(SCT) in the United States and it is estimated that there are 7 thousand new cases in Brazil. Eighty
percent of patients are fertile males. Infertility in this patient group is due to 3 main factors resulting
from spinal cord lesions: erectile dysfunction, ejaculatory disorder and low sperm counts. Erectile
dysfunction has been successfully treated with oral and injectable medications, use of vacuum de-
vices and penile prosthesis implants. The technological improvement in penile vibratory stimulation
devices (PVS) and rectal probe electro-ejaculation (RPE) has made such procedures safer and acces-
sible to patients with ejaculatory dysfunction. Despite the normal number of spermatozoa found in
semen of spinal cord-injured patients, their motility is abnormal. This change does not seem to be
related to changes in scrotal thermal regulation, frequency of ejaculation or duration of spinal cord
damage but to factors related to the seminal plasma. Despite the poor seminal quality, increasingly
more men with SCT have become fathers through techniques ranging from simple homologous in-
semination to sophisticated assisted reproduction techniques such as intracytoplasmic sperm injec-
tion (ICSI).
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INTRODUCTION
In the United States, there are approximately
300,000 patients with sequelae from spinal cord
trauma (SCT), and there are a reported 10,000 new
cases every year (1). In Brazil, an estimated 7 thou-
sand new cases occur every year. Approximately 80%
of the affected patients are males of reproductive age.
Men with SCT often present fertility problems re-
lated to the neurological lesion. This patient group
faces 3 main problems concerning this issue (1-5):
first, erectile dysfunction, where both medical and
surgical treatment has provided a high resolution in-
dex; second, ejaculatory dysfunction, present in up
to 90% of the cases and requiring the use of resources
for inducing semen release; and finally, low sperm
counts. The number of spermatozoa in the ejaculate
of spinal cord-injured patients is generally within
normal ranges. However, motility is low, approxi-
mately 20% as compared to the 70% rate usually
found in healthy patients. Infertility among spinal
cord-injured patients usually results from the sum of
all these factors. This present report aims to provide
a critical analysis of each involved factor, the patho-
physiology and the currently available treatment
modalities.
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ERECTILE DYSFUNCTION
The change of erectile quality in the spinal
cord-injured patient is directly related to the lesion
level and the extent of impairment. Two components
act together in the erectile physiology: the reflex and
the psychogenic components (6). The reflex com-
ponent is induced by tactile stimulation of the geni-
tal organs; impulses run through the pudendal nerve
(somatic innervation) until they reach the sacral erec-
tion center. The parasympathetic nuclei are activated
and erection is achieved through the cavernous
nerves. On the other hand, psychogenic stimulation
results from audio-visual or imaginary stimuli and
depends on the modulation of the spinal erection
centers (T11-L2 and S2-S4). In order to activate the
erection process, cerebral impulses are transmitted
through the sympathetic (inhibiting norepinephrine
release), parasympathetic (releasing nitric oxide and
acetylcholine) and somatic (releasing acetylcholine)
tracts.
When the lesion occurs at the sacral level,
the psychogenic erection component is preserved but
the reflex mechanism is not. Under these circum-
stances, the cerebral stimulus is transmitted through
sympathetic fibers thus inhibiting the norepinephrine
release, while acetylcholine and nitric oxide are re-
leased through synapses existing in somatic and post-
ganglionic parasympathetic neurons. When compared
with sacral fibers, the lower number of synapses be-
tween thoracic-lumbar fibers and postganglionic para-
sympathetic neurons results in partial erection. In
patients with spinal cord lesion above the T9 level,
psychogenic erection is usually absent (1,6).
Treatment of Erectile Dysfunction
The first step consists of orientating the pa-
tient about the impact of SCT on sexual dysfunction
and the types of erection he can possibly achieve.
Before treatment, it is fundamental that pa-
tients be instructed to empty their bladders prior to
initiating the sexual stimulation. This maneuver aims
to avoid the occurrence of autonomic dysreflexia
(AD) (7,8).
Therapeutic options for erectile dysfunction
(9-20) in these patients include the use of oral medi-
cation, intracavernous injection, vacuum devices and
penile prostheses. The selection of the type of treat-
ment depends on adaptation and individual response
to the selected modality, though it should always start
with the less invasive methods.
Sildenafil, an oral medication introduced in
the market approximately 6 years ago, is a potent in-
hibitor of type-5 phosphodiesterase (PDE5), respon-
sible for degradation of cyclic guanosine monophos-
phate (cGMP). Sildenafil enhances the relaxing ef-
fect of nitric oxide (NO) released in response to sexual
stimulation by increasing cGMP concentrations in the
cavernous body. This results in increased penile ri-
gidity and tumescence. Success rates among spinal
cord-injured patients range from 75 to 94% (10-12).
For the majority of writers, the best results are
achieved by patients with partial neurological dam-
age. On the other hand, Sanchez Ramos et al. (11)
demonstrated that there was no difference in the re-
sponse to medication when comparing either the se-
verity of neurological impairment or the level of spi-
nal cord lesions. Adverse effects resulting from
Sildenafil use among patients with SCT do not differ
from those observed in the general population and
range from 10 to 42%. Headaches (17%) and face
rubor are among the most frequent side effects (12).
Tadalafil and vardenafil, 2 other inhibitors of phos-
phodiesterase that have been more recently used, pro-
duce effects similar to Sildenafil in spinal cord-in-
jured patients (9,10,13).
Apomorphine, a dopaminergic agonist, acts
by stimulating the D2 receptors in the paraventricular
nucleus of the hypothalamus. This activates pro-erec-
tile central pathways involving NO and oxytocin, thus
leading to erection (10,14). The only study on the
efficacy of apomorphine for erectile dysfunction in
spinal cord-injured patients was performed by Strebel
et al. (14). Only 2 out of 22 patients presented satis-
factory erections following the use of sublingual apo-
morphine.
Intracavernous injections of vasoactive sub-
stances provide a success rate of 95%, defined by
achievement of an erection suitable for penetration
(15,16). Treatment should start with low dosing due
to the risk of priapism (papaverine 7.5 mg, or pros-
taglandin E1 2µg). In addition to priapism, other po-
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tential complications for this treatment modality in-
clude penile excoriation, infection and fibrosis of the
cavernous body.
Vacuum devices (17,18) promote an increase
in penile blood flow due to the negative pressure they
generate. Once the erection is obtained, a constric-
tion ring is placed at the base of the penis. Patients
should not keep this ring in place for more than 30
minutes due to the risk of ischemic penile damage.
Denil et al. (17) assessed 20 patients with SCT using
vacuum devices. After 3 months, 93% of the men re-
ported proper erections, but this index decreased to
41% after 6 months, with the most frequent complaint
being early loss of erection rigidity. Its use is con-
traindicated in patients with blood dyscrasias, or those
using anticoagulants due to complications such as
ecchymoses, skin edema and abrasions.
The implantation of a penile prosthesis (19)
is usually the last therapeutic option, and is attempted
when all previously described techniques have
failed. There is a wide range of materials and mod-
els that adapt to each patient’s condition and needs.
Semi-rigid prostheses have the advantage of easy
implantation, a low mechanical failure rate and low
cost. The disadvantages are that the penis remains
constantly in an erect position, in addition to pre-
senting a higher risk of penile erosion. Inflatable
prostheses promote an appearance more resembling
that of a normal erection, however their implanta-
tion is more laborious and costs are quite high. In
patients with SCT, the penile prosthesis aims also
to assist in the management of urinary incontinence,
making the adaptation of external penile collectors
easier (20). Kimoto & Iwatsubo (20) assessed 82
spinal cord-injured patients. Follow-up time ranged
from 1 to 10 years (mean 4 years) and obtained a
satisfaction rate of 64% for sexual function and 93%
for adaptation of the urine collector. Complications
occurred in 13.3% of cases, with the most frequent
being extrusion of the prosthesis and cavernous in-
fection.
EJACULATORY DYSFUNCTION
Ejaculatory dysfunction is one of the main
factors for infertility in patients victimized by SCT
(1,3-5,21). In 1948, Horne et al. (3) reported that
ejaculation was present in only 18% of the 84 pa-
tients under study whose spinal cord trauma occurred
above the sacral level. Talbot (4) assessed 408 pa-
tients and found an even lower value – only 10% of
reported antegrade ejaculation.
Normal ejaculatory function, a primarily
sympathetic phenomenon, consists in a complex and
coordinated sequence of striated and smooth mus-
cular contractions, which results in the antegrade
emission and expulsion of sperm. The dorsal nerve
of the penis transmits the afferent impulse produced
by the tactile stimulation through the pudendal nerve
to the cerebral centers. The efferent stimulus fol-
lows, occurring through the anterolateral column of
the spinal cord until it reaches the sympathetic gan-
glionic chain (T10 to L2), the hypogastric plexus
anterior to the aorta. Short postganglionic fibers di-
vide into branches and reach the prostate, vasa def-
erentia and seminal vesicles. Adrenergic neurons
stimulate the emission of sperm into the posterior
urethra, while the bladder neck closes simulta-
neously, which prevents retrograde ejaculation.
Through the somatic innervation (S2-S4), involun-
tary contractions of the periurethral musculature
(bulbocavernous and ischiocavernous muscles) and
the pelvic floor cause the expulsion of seminal fluid
through the distal urethra distal, thus completing the
ejaculatory event.
Methods for Assisted Ejaculation
Penile vibratory stimulation (PVS) and rec-
tal probe electro-ejaculation (RPE) are methods cur-
rently used for this purpose (3,22-27). The vibratory
stimulation was first reported by Sobrero et al. (23)
in 1965 as a method for inducing ejaculation in hu-
mans. In PVS, a vibratory device is placed in contact
with the glans and frenulum preputii in order to stimu-
late ejaculation. Devices with high-amplitude move-
ment (> 2.5 mm) have shown better results when com-
pared with low amplitude devices (< 2.5 mm), with
success rates of 60% to 80% and 30% to 40% respec-
tively (28,29). Since it is a non-invasive method, the
process can be used at home by the patient himself,
with no need for medical assistance. Due to the low
local tactile sensitivity, patients should be instructed
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towards intermittent and non-prolonged use to avoid
penile damage. The PVS shows better results in men
with spinal cord lesion located above the thoracic-
lumbar efferent center (T10-L2); that is, when the
ejaculatory reflex arc remains intact.
Electro-ejaculation was described by Horne
et al. (3) in 1948 and is used in cases where PVS
fails. It has a higher success rate than PVS – about
90% to 100%. It consists in introducing a rectal probe
and applying direct electric stimulation on the sym-
pathetic efferent fibers of the hypogastric nerve
through the anterior rectal wall. The procedure is usu-
ally well tolerated and only 5% of patients require
sedation or anesthesia for reducing the discomfort.
Inadvertent damage to rectal mucosa can occur, and
the performance of rectosigmoidoscopy before and
after the procedure is routinely recommended. An
additional disadvantage is the fact that the procedure’s
execution is restricted to outpatient/hospital regimen
and provides low quality semen (30) (Table-1).
In the presence of retrograde ejaculation, pH
changes and potential infections make the vesical en-
vironment hostile to the ejaculate, thus demanding urine
alkalinization 24-48 hours before the procedure. For
Author
Rutkowski et al. (22)
Heruti et al. (25)
Nehra et al. (26)
Hultling et al. (32)
Sonksen et al. (59)
Brindsen et al. (60)
Kolletis et al. (61)
Shieh et al. (62)
Buch et al. (63)
Bennett et al. (64)
  N Lesion Level
NR*
Cervical - 29
Thoracic - 50
Lumbar - 05
Cervical
Thoracic
C2 - L3
-
C5 - L1
Cervical - 10
Thoracic - 16
Lumbar - 1
T3-T12-9
C6 - 1
-
Thoracic
 Method
PVS
RPE
RPE
PVS
RPE
PVS
RPE
PVS
RPE
PVS
RPE
RPE
RPE
RPE
RPE
  Ejaculation Rate Pregnancy Rate
*NR = non-reported data.
Table 1 – Results with vibratory ejaculation (PVS) and electro-ejaculation (RPE) for obtaining semen and pregnancy rate
in patients with spinal cord trauma.
67%
97%
100%
44%
95%
NR
NR
79%
100%
17,8%
62,5%
100%
100%
89%
53%
55% (17/31)
70% (18/23)
63% (17/27)
64% (16/25)
32% 0(9/28)
51% (18/35)
40% 00(2/5)
80% 0(8/10)
50% 00(3/6)
40% 0(4/10)
113
0
84
0
78
0
25
0
28
0
56
027
010
018
037
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this, sodium bicarbonate is orally administered the day
before surgery, or a conservative medium, such as
modified human tubal fluid (HTF), is instilled into the
bladder after its emptying. Retrograde ejaculate is col-
lected by bladder catheterization (24). Patients under-
going RPE or PVS and with lesions located above the
T6 level are more susceptible to autonomic dysreflexia
and require continuous monitoring or previous prophy-
laxis, such as administration of 20 mg of nifedipine 15
minutes before performing the procedure (31).
Alternative methods, such as sperm aspira-
tion from the epididymis or testis by microsurgery or
puncture, can be used as well (MESA - microsurgical
epididymal sperm aspiration, PESA - percutaneous
epididymal sperm aspiration, TESE - testicular sperm
extraction, TESA - testicular sperm aspiration). They
have the inconvenience of obtaining a small seminal
volume and a low number of spermatozoa in relation
to ejaculate, and these methods are reserved for cases
with obstructive azoospermia or when both PVS and
RPE have failed (32,33).
SPERM QUALITY
The quality of the ejaculate is yet another ad-
ditional obstacle for patients with SCT, even follow-
ing successful sperm collection by the several meth-
ods described above. Despite the absence of agreement
among authors, the number of spermatozoa in spinal
cord-injured patients is believed to be normal and, con-
trary to the previous thinking, there is no progressive
decline over the years following trauma if the men have
proper urological follow-up. Brackett et al. (34) con-
ducted one study with 125 patients victimized by SCT.
They analyzed spermiograms collected at intervals of
1 to 12 weeks, with an average of 5 samples per pa-
tient, over 24 months. This study found no differences
in the concentration, total number and motility of sper-
matozoa in the ejaculate in relation to the time lapsed.
However, other authors have reported increased sperm
fragility, low motility (mean of 20% in comparison with
70% in healthy patients) and the presence of necrosper-
mia. No correlation was demonstrated between these
findings and the lesion level, patient’s age, time since
the trauma, or frequency of ejaculations (35,36). The
exact moment where the seminal quality starts to de-
cline is still an issue for further investigation; how-
ever, it can possibly occur during the first months fol-
lowing the spinal cord lesion. It is difficult to assess
the patients during the acute phase of SCT because
they lack the emotional and physical conditions that
would allow them to participate in assisted reproduc-
tion procedures. Brackett et al. (35) described a low
success index in assisted ejaculation for patients at less
than 1 year from the trauma, and once the semen was
obtained, there was a small amount of spermatozoa,
making the assessment difficult during the acute pe-
riod. In a prospective study, Mallidis et al. (37) assessed
7 men with SCT and identified a decline in semen qual-
ity starting 16 days after SCT, thus recommending semi-
nal cryopreservation in the acute phase. Padron et al.
(38) found that the effects of sperm freezing were simi-
lar both in healthy patients and those with SCT; that is,
there was decreased motility ranging from 60% to 80%
after thawing. Due to the inferior seminal quality in
spinal cord-injured patients, there is no apparent ad-
vantage with routine seminal cryopreservation in this
group of patients. The process would be indicated in
specific cases, such as the patient’s personal wish, dif-
ficulty of transporting the ejaculate to the assisted re-
production centers, or limitations in time coordination
between sample collection and use (33).
Causes of Low Sperm Quality
The main hypotheses formulated to explain
the low sperm quality in spinal cord-injured patient
are increase in scrotal temperature, aggression result-
ing from methods used in bladder emptying, infre-
quent ejaculations, altered hormonal environment,
leukospermia, urinary tract infections and factors in
seminal plasma that regulate sperm motility (39-57).
Scrotal Temperature
The similarity in seminal changes observed
among patients with SCT has stimulated the search
for common factors that could explain them. The
increase in scrotal temperature is basically due to a
scrotal thermoregulatory change by the autonomic
nervous system and to the long periods which such
patients remain seated in wheelchairs. Early studies
have established a correlation between the increase
in scrotal temperature and the low motility of sper-
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matozoa. Wang et al. (39) identified an initial scrotal
temperature 1.2º C higher among spinal cord-injured
patients compared to the control group. On the other
hand, Brackett et al. (40) analyzed 66 patients with
SCT and 21 controls and did not identify any differ-
ences in scrotal temperature or in seminal quality.
Frequency of Ejaculation
Siosteen et al. (41) reported an increase in
seminal volume and the total number of motile sper-
matozoa in 16 patients who presented repeated ejacu-
lations for a period of 4 to 6 months. On the other
hand, Sonksen et al. (36) did not identify any changes
in seminal quality when assessing 19 patients for a 1-
year period on a weekly PVS program.
Method of Urinary Bladder Drainage
Rutkowski et al. (42) evaluated the ejaculate
of patients with SCT and identified a better percent-
age of sperm motility in patients who used intermit-
tent bladder catheterization compared to other meth-
ods (indwelling bladder catheter and suprapubic
drainage), probably due to the lower rate of urinary
infection.
Endocrine Dysfunction
Normality of the hypothalamus-pituitary-go-
nad axis is fundamental for normal sperm produc-
tion. Brackett et al. (43) identified a normal hormonal
pattern in spinal cord-injured patients. In turn, Naderi
et al. (44) identified decreased LH and FSH levels,
suggesting that this contributed to the seminal changes
to some degree. However, Morton (45) suggested that
such changes could be caused by sleep apnea, which
is present in 40% of patients with SCT, and associ-
ated with hypogonadotropic hypogonadism.
Leukospermia and Urinary Tract Infections
Bacteriuria was described in 60-70% of an-
nual tests in patients with SCT. Wolff et al. (46) reported
the association between leukospermia and a decrease
in the number and motility of spermatozoa. Ohl et al.
(47) have also verified the association between uri-
nary infections and poorer sperm quality. However,
seminal improvement is limited following treatment,
still maintaining lower levels than healthy patients.
Seminal Plasma
Several authors have investigated the role of
seminal plasma as the cause of poor sperm quality.
When mixed with spermatozoa from normal men, semi-
nal plasma from patients with SCT promotes a decrease
in their motility. Contrarily, the addition of seminal
plasma from normal men improves sperm motility in
patients with SCT (48). Spermatozoa collected from
the vas deferens of patients with spinal cord lesions
show higher motility when compared to those obtained
from the ejaculate and seminal vesicles, suggesting that
the worsening quality could be associated with factors
that are present in prostate or seminal vesicle secre-
tions (49,50). Changes in the seminal plasma have been
found following SCT installation, such as reduced lev-
els of fructose levels, albumin, glutamic oxaloacetic
transaminase, alkaline phosphatase and prostate-spe-
cific antigen (PSA), and increased levels of chloride
(51,52), reactive oxygen species (ROS) (53) and
cytokine (54,55). The low fructose concentration in
the semen from patients with SCT, which is a major
energy source for the spermatozoa, has been pointed
out as a co-factor in asthenospermia. Reactive oxygen
species such as superoxide anion, hydrogen peroxide,
peroxyl and hydroxyl are being correlated with low
viability and morphological changes in spermatozoa
(56). High cytokines (54) indicate an immunological
ground for infertility. Cohen et al. (55) reported im-
provement in sperm motility following cytokine inac-
tivation by monoclonal antibodies. Anti-sperm antibod-
ies have also been reported as a potential cause of low
seminal quality due to their high titers in such situa-
tions (57).
ASSISTED REPRODUCTION
TECHNIQUES
Due to their low seminal quality, spinal cord-
injured patients undergoing sperm collection usually
require assistance for achieving fecundation and con-
sequently, fatherhood. Factors that help determine the
method to be employed are the patient’s seminal pa-
rameters, their partner’s age, their wife’s health con-
ditions and the procedure costs. The most frequently
used techniques are intrauterine insemination (IUI),
in vitro fertilization (IVF), gamete intrafallopian trans-
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fer (GIFT) or zygote intrafallopian transfer (ZIFT)
and intracytoplasmic sperm injection (ICSI) in the
oocyte (58).
In IUI, the semen is processed and the sper-
matozoa are separated from the seminal plasma. The
partner is monitored by ultrasound or urine tests in
order to detect the moment when ovulation occurs.
Spermatozoa are introduced into the uterus through a
catheter. The seminal concentration should be supe-
rior to 5.0 x 106/mL following processing so that
the technique can be used. Pregnancy rates oscil-
lated from 8% to 12% per cycle. When seminal con-
centration is between 2 and 5 million, IVF, GIFT or
ZIFT must be preferred. In IVF, spermatozoa are left
with the ovules and, following fertilization, the em-
bryos are transferred to the uterus, with pregnancy
rates of 20% to 40%. GIFT and ZIFT consist of trans-
ferring gametes or the zygote into the uterine tube.
Due to the procedure’s more invasive nature, they
are currently little used. ICSI is the injection of a
single spermatozoon into the ovule, with subsequent
transfer to the maternal uterus following embryo
formation. It is indicated in cases where the previ-
ously mentioned methods have failed and in those
where the seminal concentration is lower than 2 X
106/mL. The success rate (by pregnancy) is also
around 20% and 40%. Few studies have reported
pregnancy rates (pregnancy/number of couples), or
fecundation rates (pregnancy/number of pregnancy
trials) in spinal cord-injured patients with assisted
reproduction methods, ranging from 32% to 80%
(22,25,26,32,59,60-64) (Table-1).
CONCLUSION
Difficulties leading the patient with SCT to
infertility are being progressively transposed due to
advances in research and technology area. Methods
for treating erectile dysfunction (oral and injectable
medication, vacuum devices and prosthesis) and
ejaculatory dysfunction (PVS, RPE, MESA, PESA,
TESA and TESE) have contributed to this. Current
studies have tried to establish factors existing in the
seminal plasma as being responsible for the low sperm
quality, even if there are no definitive results as yet.
Currently, assisted ejaculation and reproduction have
tried to answer this deficiency and increase the
chances of patients with SCT in reaching their goal
of fatherhood.
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